Campbell & CO Investment Adviser LLC Amphastar Pharmaceuticals, Inc. Transaction History
Campbell & CO Investment Adviser LLC
- $1.24 Billion
- Q4 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 47,566 shares of AMPH stock, worth $1.51 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
47,566Holding current value
$1.51 Million% of portfolio
0.14%Shares
13 transactions
Others Institutions Holding AMPH
# of Institutions
282Shares Held
35.4MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$189 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$86.2 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$58.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.53MShares$48.6 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$43.6 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.56B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...